pyrroles has been researched along with Cross Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chetia, P; Neog, N; Phukan, U; Puzari, M; Sharma, M | 1 |
| Gambassi, G; Lapane, KL; Motzkus-Feagans, CA; Pakyz, A; Polk, R | 1 |
1 review(s) available for pyrroles and Cross Infection
| Article | Year |
|---|---|
Klebsiella oxytoca and Emerging Nosocomial Infections.
Topics: Adult; Bacterial Toxins; Benzodiazepines; Cross Infection; Humans; Infant, Newborn; Klebsiella; Klebsiella Infections; Klebsiella oxytoca; Pyrroles | 2021 |
1 other study(ies) available for pyrroles and Cross Infection
| Article | Year |
|---|---|
Statin use and the risk of Clostridium difficile in academic medical centres.
Topics: Academic Medical Centers; Adult; Age Distribution; Aged; Aged, 80 and over; Atorvastatin; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Confidence Intervals; Cross Infection; Databases, Factual; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Logistic Models; Male; Middle Aged; Odds Ratio; Pyrroles; Reference Values; Risk Assessment; Sex Distribution; Simvastatin; United States; Young Adult | 2012 |